MISSISSAUGA, Ontario–(BUSINESS WIRE)–Covalon Technologies Ltd. (the “Company” or “Covalon”) (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its fiscal 2025 third quarter results for the period ended June 30, 2025, along with a number of important recent achievements and highlights. Brent Ashton, Covalon’s Chief Executive Officer, reported, “The Covalon team has made numerous advancements on our strategic priorities in the past few months. This solid progre